Skip to main content
SpringerLink
Log in

Management of Chronic Arthritis Pain in the Elderly

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Musculoskeletal pain in the elderly is common and disabling. As the conditions causing rheumatic pain, including osteoarthritis, inflammatory arthritis and soft-tissue conditions such as tendonitis and bursitis, are, for the most part, not curable, pain control is paramount in order to maintain quality of life. Pain management should be multimodal and tailored to the individual patient, and will likely include a combination of both nonpharmacological and pharmacological interventions.

Nonpharmacological treatments begin with education of the patient, encouragement to practise self-management strategies and attention to healthy life habits such as weight control and regular physical activity and exercise. Advice in this regard may be effectively given by healthcare professionals other than physicians. Although herbal products and nutritional supplements are commonly used by patients, studies of their efficacy and safety, especially in the elderly, are limited. In contrast, topical applications, and in particular those containing NSAIDs, are being used more frequently, are associated with fewer adverse effects than oral preparations and offer a new and safer treatment alternative. Similarly, intra-articular and soft-tissue injections of corticosteroids provide an easy and cost-effective option for symptom relief with minimal risk.

The use of any pharmacological agent in the elderly should be tempered with caution regarding increased sensitivity to medications, drug-drug interactions and associated co-morbidities. Therefore, the elderly will often require down-adjustment of dosage and careful attention to the risk/benefit ratio of the treatment. There is, however, no single ideal pain medication for management of rheumatic pain. The four broad categories of treatments, namely simple analgesics (i.e. paracetamol [acetaminophen]), NSAIDs, stronger analgesics (i.e. opioids) and adjuvant drugs, each have unique and particular concerns regarding their adverse effect profiles. The continued use of any medication should also be repeatedly assessed to ensure that efficacy is maintained. Throughout the treatment period, physicians must remain vigilant for emergent adverse effects.

Patients and physicians should have realistic outcome goals for effective rheumatic pain management. Although complete pain relief is seldom achieved, modulation of pain and the associated components of sleep disturbance, fatigue and mood disorder will improve overall quality of life in the elderly. However, barriers to effective pain management from both the patient and the healthcare professional perspectives still exist, and will be overcome only by educational efforts.

Successful rheumatic pain management in the elderly should begin with an accurate diagnosis by the physician, and patients must be realistic in their expectations. Treatments should be multimodal, with attention given to the co-morbidities of pain as well as the global health status of the patient. Whether or not an outcome is favourable should be determined not only by the treatment’s impact on pain but also by its capacity to improve function and enhance quality of life. The wider range of treatment options now available is both useful and encouraging for the physician managing musculoskeletal aches and pain in the elderly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

Similar content being viewed by others

References

  1. Barkin RL, Barkin SJ, Barkin DS. Pharmacotherapeutic management of pain with a focus directed at the geriatric patient. Rheum Dis Clin North Am 2007; 33: 1–31

    Article  PubMed  Google Scholar 

  2. McCarberg BH. Rheumatic diseases in the elderly: dealing with rheumatic pain in extended care facilities. Rheum Dis Clin North Am 2007; 33: 87–108

    Article  PubMed  Google Scholar 

  3. Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006; 54: 226–9

    Article  PubMed  Google Scholar 

  4. Kelsey JL, White AA. Epidemiology and impact of low back pain. Spine 1980; 5: 133–42

    Article  PubMed  CAS  Google Scholar 

  5. Lawrence RC, Felson DT, Helmick CG, et al., for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States part II. Arthritis Rheum 2008; 58: 26–35

    Article  PubMed  Google Scholar 

  6. Helmick CG, Felson DT, Lawrence RC, et al., for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States part I. Arthritis Rheum 2008; 58: 15–25

    Article  PubMed  Google Scholar 

  7. Centers for Disease Control and Prevention (CDC). Prevalence of disabilities and associated health conditions among adults — United States, 1999. MMWR Morb Mortal Wkly Rep 2001; 50: 120–5

    Google Scholar 

  8. Harkness EF, Macfarlane GJ, Silman AJ, et al. Is musculoskeletal pain more common now than 40 years ago? Two population-based cross-sectional studies. Rheumatology 2005; 44: 890–5

    Article  PubMed  CAS  Google Scholar 

  9. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 2004; 109: 514–9

    Article  PubMed  Google Scholar 

  10. Skevington SM. Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL. Pain 1998; 76: 395–406

    Article  PubMed  CAS  Google Scholar 

  11. AGS Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009; 57: 1331–46

    Article  Google Scholar 

  12. Blumstein H, Gorevic PD. Rheumatologic illnesses: treatment strategies for older adults. Geriatrics 2005; 60(6): 28–35

    PubMed  Google Scholar 

  13. Fitzcharles MA, Shir Y. New concepts in rheumatic pain. Rheum Dis Clin North Am 2008; 34: 267–83

    Article  PubMed  Google Scholar 

  14. McDougall JJ. Arthritis and pain: neurogenic origin of joint pain. Arthritis Res Ther 2006; 8: 220–30

    Article  PubMed  CAS  Google Scholar 

  15. Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br J Anaesthesia 2001; 87: 3–11

    Article  CAS  Google Scholar 

  16. Coderre TJ, Katz J, Vaccarino AL, et al. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259–85

    Article  PubMed  CAS  Google Scholar 

  17. Bolay H, Moskowitz MA. Mechanisms of pain modulation in chronic syndromes. Neurology 2002; 59: S2–7

    Article  PubMed  CAS  Google Scholar 

  18. Schaible HG, Del Rosso A, Matucci-Cerinic M. Neurogenic aspects of inflammation. Rheum Dis Clin North Am 2005; 3: 77–101

    Article  Google Scholar 

  19. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984; 7: 309–38

    Article  PubMed  CAS  Google Scholar 

  20. Kidd BL. Osteoarthritis and joint pain. Pain 2006; 123: 6–9

    Article  PubMed  Google Scholar 

  21. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356–61

    Article  PubMed  CAS  Google Scholar 

  22. Krasnokutsky S, Samuels J, Abramson SB. Osteoarthritis in 2007. Bull Hosp Jt Dis 2007; 65: 222–8

    Google Scholar 

  23. Carrino JA, Blum J, Parellada JA, et al. MRI of bone marrow edema-like signal in the pathogenesis of subchondral cysts. Osteoarthritis Cartilage 2006; 14: 1081–5

    Article  PubMed  CAS  Google Scholar 

  24. Findlay DM. Vascular pathology and osteoarthritis. Rheumatology 2007; 46: 1763–8

    Article  PubMed  CAS  Google Scholar 

  25. Chakour MC, Gibson SJ, Bradbeer M, et al. The effect of age on A delta- and C-fibre thermal pain perception. Pain 1996; 64: 143–52

    Article  PubMed  CAS  Google Scholar 

  26. Gibson SJ, Gorman MM, Helme RD. The assessment of pain in the elderly using cerebral event related potentials. In: Bond MR, Charlton JE, Woolf CJ, editors. Proceedings of the Vth World Congress on Pain. Amsterdam: Elsevier, 1991: 527–35

    Google Scholar 

  27. Washington LL, Gibson SJ, Helme RD. Age-related differences in the endogenous analgesic response to repeated cold water immersion in human volunteers. Pain 2000; 89: 89–96

    Article  PubMed  CAS  Google Scholar 

  28. Edwards RR, Fillingim RB, Ness TJ. Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain 2003; 101: 155–65

    Article  PubMed  Google Scholar 

  29. Larivière M, Goffaux P, Marchand S, et al. Changes in pain perception and descending inhibitory controls start at middle age in healthy adults. Clin J Pain 2007; 23: 506–10

    Article  PubMed  Google Scholar 

  30. Bellamy N, Sothern RB, Campbell J. Rhythmic variations in pain perception in osteoarthritis of the knee. J Rheumatol 1990; 17: 364–72

    PubMed  CAS  Google Scholar 

  31. Fitzcharles MA, Almahrezi A, Shir Y. Pain: understanding and challenges for the rheumatologist. Arthritis Rheum 2005; 52: 3685–92

    Article  PubMed  Google Scholar 

  32. Fitzcharles MA, DaCosta D, Ware MA, et al. Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis. J Pain 2009; 10: 300–5

    PubMed  Google Scholar 

  33. Guedj D, Weinberger A. Effect of weather conditions on rheumatic patients. Ann Rheum Dis 1990; 49: 158–9

    Article  PubMed  CAS  Google Scholar 

  34. McAlindon T, Formica M, Schmid CH, et al. Changes in barometric pressure and ambient temperature influence osteoarthritis pain. Am J Med 2007; 120: 429–34

    Article  PubMed  Google Scholar 

  35. Morin CM, Gibson D, Wade J. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 1998; 14: 311–4

    Article  PubMed  CAS  Google Scholar 

  36. Hamerman D. The biology of osteoarthritis. N Eng J Med 1989; 320: 1322–30

    Article  CAS  Google Scholar 

  37. Weiner DK. Office management of chronic pain in the elderly. Am J Med 2007; 120: 306–15

    Article  PubMed  Google Scholar 

  38. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 43: 1905–15

    Article  Google Scholar 

  39. Ostor AJ. Beyond methotrexate: biologic therapy in rheumatoid arthritis. Clin Med 2005; 5: 222–6

    PubMed  Google Scholar 

  40. Garcia GM, McCord GC, Kumar R. Hydroxyapatite crystal deposition disease. Semin Musculoskelet Radiol 2003; 7: 187–93

    Article  PubMed  Google Scholar 

  41. Gosens T, Hofstee DJ. Calcifying tendinitis of the shoulder: advances in imaging and management. Curr Rheumatol Rep 2009; 11: 129–34

    Article  PubMed  Google Scholar 

  42. Monsivais D, McNeill J. Multicultural influences on pain medication attitudes and beliefs in patients with non-malignant chronic pain syndromes. Pain Manag Nurs 2007; 8: 64–71

    Article  PubMed  Google Scholar 

  43. Zhang W, Doherty M, Arden N, et al., EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 669–81

    Article  PubMed  CAS  Google Scholar 

  44. Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. Epub 2010 Feb 11

    Google Scholar 

  45. National Collaborating Centre for Chronic Conditions. Osteoarthritis: the care and management of osteoarthritis in adults. London: National Institute for Health and Clinical Excellence (NICE), 2008 Feb 22: Clinical guideline no. 59

    Google Scholar 

  46. Otis JAD, McGeeney B. Managing pain in the elderly. Clin Geriatr 2001; 9: 82–8

    Google Scholar 

  47. Farrar JT, Portenoy RK, Berlin JA, et al. Defining the clinically important difference in pain outcome measures. Pain 2000; 88: 287–94

    Article  PubMed  CAS  Google Scholar 

  48. Somers TJ, Keefe FJ, Godiwala N, et al. Psychosocial factors and the pain experience of osteoarthritis patients: new findings and new directions. Curr Opin Rheumatol 2009; 21: 501–6

    Article  PubMed  Google Scholar 

  49. Sullivan MJ, Martel MO, Tripp D, et al. The relation between catastrophizing and the communication of pain experience. Pain 2006; 122: 282–8

    Article  PubMed  CAS  Google Scholar 

  50. Yocum DE, Castro WL, Cornett M. Exercise, education, and behavioral modification as alternative therapy for pain and stress in rheumatic disease. Rheum Dis Clin North Am 2000; 26: 145–59

    Article  PubMed  CAS  Google Scholar 

  51. Patel A, Buszewicz M, Beecham J, et al. Economic evaluation of arthritis self management in primary care. BMJ 2009 Sep 22; 339: b3532

    Article  PubMed  Google Scholar 

  52. Buszewicz M, Rait G, Griffin M, et al. Self management of arthritis in primary care: randomized controlled trial. BMJ 2006 Oct 28; 333: 879–82

    Article  PubMed  Google Scholar 

  53. Astin JA. Mind-body therapies for the management of pain. Clin J Pain 2004; 20: 27–32

    Article  PubMed  Google Scholar 

  54. Reid MC, Papaleontiou M, Ong A, et al. Self-management strategies to reduce pain and improve function among older adults in community settings: a review of the evidence. Pain Med 2008; 9: 409–24

    Article  PubMed  Google Scholar 

  55. Dixon KE, Keefe FJ, Scipio CD, et al. Psychological interventions for arthritis pain management in adults: a meta-analysis. Health Psychol 2007; 26: 241–50

    Article  PubMed  Google Scholar 

  56. Zhang W, Robertson J, Jones AC, et al. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008; 67: 1716–23

    Article  PubMed  CAS  Google Scholar 

  57. Gloth MJ, Matesi AM. Physical therapy and exercise in pain management. Clin Geriatr Med 2001; 17: 525–35

    Article  PubMed  CAS  Google Scholar 

  58. Jonsdottir IH, Hoffmann P, Thoren P. Physical exercise, endogenous opioids and immune function. Acta Physiol Scand Suppl 1997; 640: 47–50

    PubMed  CAS  Google Scholar 

  59. Roddy E, Zhang W, Doherty M, et al. Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee: the MOVE consensus. Rheumatology 2005; 44: 67–73

    Article  PubMed  CAS  Google Scholar 

  60. Bosomworth NJ. Exercise and knee osteoarthritis: benefit or hazard? Can Fam Physician 2009; 55: 871–8

    PubMed  Google Scholar 

  61. Walsh NE, Hurley MV. Evidence based guidelines and current practice for physiotherapy management of knee osteoarthritis. Musculoskeletal Care 2009; 7: 45–56

    Article  PubMed  Google Scholar 

  62. Fransen M, McConnell S, Hernandez-Molina G, et al. Exercise for osteoarthritis of the hip. Cochrane Database Syst Rev 2009 Jul 8; (3): CD007912

    Google Scholar 

  63. Focht BC, Rejeski WJ, Ambrosius WT, et al. Exercise, self-efficacy, and mobility performance in overweight and obese older adults with knee osteoarthritis. Arthritis Rheum 2005; 53: 659–65

    Article  PubMed  Google Scholar 

  64. Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women: The Framingham Study. Ann Intern Med 1992; 116: 535–9

    PubMed  CAS  Google Scholar 

  65. Christensen R, Bartels EM, Astrup A, et al. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2007; 66: 433–9

    Article  PubMed  Google Scholar 

  66. Beaudreuil J, Bendaya S, Faucher M, et al. Clinical practice guidelines for rest orthosis, knee sleeves, and unloading knee braces in knee osteoarthritis. Joint Bone Spine 2009; 76: 629–36

    Article  PubMed  Google Scholar 

  67. Brouwer RW, Jakma TS, Verhagen AP, et al. Braces and orthoses for treating osteoarthritis of the knee. Cochrane Database Syst Rev 2005 Jan 25; (1): CD004020

    Google Scholar 

  68. Bono CM, Berberian WS. Orthotic devices: degenerative disorders of the foot and ankle. Foot Ankle Clin 2001; 6: 329–40

    Article  PubMed  CAS  Google Scholar 

  69. Osiri M, Welch V, Brosseau L, et al. Transcutaneous electrical nerve stimulation for knee osteoarthritis. Cochrane Database Syst Rev 2000; (4): CD002823

    Google Scholar 

  70. Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain 2003; 4: 109–21

    Article  PubMed  Google Scholar 

  71. Fiechtner JJ, Brodeur RR. Manual and manipulation techniques for rheumatic disease. Med Clin North Am 2002; 86: 91–103

    Article  PubMed  Google Scholar 

  72. Boisset M, Fitzcharles MA. Alternative medicine use by rheumatology patients in a universal health care setting. J Rheumatol 1994; 21: 148–52

    PubMed  CAS  Google Scholar 

  73. Ernst E. Complementary treatments in rheumatic diseases. Rheum Dis Clin North Am 2008; 34: 455–67

    Article  PubMed  Google Scholar 

  74. Kikuchi M, Matsuura K, Matsumoto Y, et al. Bibliographical investigation of complementary alternative medicines for osteoarthritis and rheumatoid arthritis. Geriatr Gerontol Int 2009; 9: 29–40

    Article  PubMed  Google Scholar 

  75. Ernst E. Musculoskeletal conditions and complementary/alternative medicine. Best Pract Res Clin Rheumatol 2004; 18: 539–56

    Article  PubMed  CAS  Google Scholar 

  76. Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology 2001; 40: 779–93

    Article  PubMed  CAS  Google Scholar 

  77. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007; 129: 210–23

    Article  PubMed  CAS  Google Scholar 

  78. McAlindon TE. Nutraceuticals: do they work and when should we use them? Best Pract Res Clin Rheumatol 2006; 20: 99–115

    Article  PubMed  Google Scholar 

  79. Black C, Clar C, Henderson R, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess 2009; 13: 1–148

    PubMed  CAS  Google Scholar 

  80. World Health Organization. WHO’s pain ladder [online]. Available from URL: http://www.who.int/cancer/palliative/painladder/en/ [Accessed 2009 Nov 19]

  81. Brandt KD, Mazzuca SA, Buckwalter KA. Acetaminophen, like conventional NSAIDs, may reduce synovitis in osteoarthritic knees. Rheumatology 2006; 45: 1389–94

    Article  PubMed  CAS  Google Scholar 

  82. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Pro Natl Acad Sci U S A 2002; 99: 13926–31

    Article  CAS  Google Scholar 

  83. Bertolini A, Ferrari A, Ottani A, et al. Paracetamol: new vistas of an old drug. CNS Drug Rev 2006; 12: 250–75

    Article  PubMed  CAS  Google Scholar 

  84. Sunshine A, Olsen NZ. Nonnarcotic analgesics. In: Wall PD, Melzack R, editors. Textbook of pain. 3rd ed. Edinburgh: Churchill Livingstone, 1994: 923–42

    Google Scholar 

  85. Ellmers SE, Parker LRC, Notarianni LJ, et al. Excretion of paracetamol in fit and frail elderly people. J Am Geriatr Soc 1991; 31 (Suppl.): 596–7

    Google Scholar 

  86. Fored CM, Ejerblad E, Lindblad P, et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 2001; 345: 1801–8

    Article  PubMed  CAS  Google Scholar 

  87. Gloth FM. Pain management in older adults: prevention and treatment. J Am Geriatr Soc 2001; 49: 188–99

    Article  PubMed  Google Scholar 

  88. Bjordal JM, Ljunggren AE, Klovning A, et al. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ 2004; 329: 1317–20

    Article  PubMed  CAS  Google Scholar 

  89. Tannenbaum H, Bombardier C, Davis P, et al., Third Canadian Consensus Conference Group. Evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference. J Rheumatol 2006; 33: 140–57

    PubMed  Google Scholar 

  90. White WB, West CR, Borer JS, et al. Risk of cardiovascular events in patients receiving celecoxib: a metaanalysis of randomized clinical trials. Am J Cardiol 2007; 99: 91–8

    Article  PubMed  CAS  Google Scholar 

  91. Soni P, Shell B, Cawkwell G, et al. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials. Curr Med Res Opin 2009; 25: 1841–51

    Article  PubMed  CAS  Google Scholar 

  92. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003; 349: 1943–53

    Article  PubMed  CAS  Google Scholar 

  93. Dominick KL, Bosworth HB, Dudley TK, et al. Patterns of opioid analgesic prescription among patients with osteoarthritis. J Pain Palliat Care Pharmacother 2004; 18: 31–46

    Article  PubMed  Google Scholar 

  94. Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999; 26: 862–9

    PubMed  CAS  Google Scholar 

  95. Caldwell JR, Rapoport RJ, Davis JC, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and open label extension trial. J Pain Symptom Manage 2002; 23: 278–91

    Article  PubMed  CAS  Google Scholar 

  96. Jovey RD, Ennis J, Gardner-Nix J, et al., Canadian Pain Society. Use of opioid analgesics for the treatment of chronic noncancer pain: a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manag 2003; 8Suppl. A: 3A–28A

    PubMed  Google Scholar 

  97. Chou R, Fanciullo GJ, Fine PG, et al., American Pain Society — American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009; 10: 113–30

    Article  PubMed  CAS  Google Scholar 

  98. Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112: 372–80

    Article  PubMed  CAS  Google Scholar 

  99. Twycross RG. Opioids. In: Wall PD, Melzack R, editors. Textbook of pain. 4th ed. London: Churchill Livingstone, 1999: 1187–214

    Google Scholar 

  100. Chen ZR, Somogyi AA, Bochner F. Polymorphic Odemethylation of codeine. Lancet 1988; 2: 914–5

    Article  PubMed  CAS  Google Scholar 

  101. Pergolizzi J, Böger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008; 8: 287–313

    Article  PubMed  Google Scholar 

  102. Pergolizzi JV, Raffa RB, Gould E. Considerations on the use of oxymorphone in geriatric patients. Expert Opin Drug Saf 2009; 8: 603–13

    Article  PubMed  CAS  Google Scholar 

  103. Lussier D, Pickering G. Pharmacological considerations in older patients. In: Beaulieu P, Lussier D, Porreca F, editors. Pharmacology of pain. Seattle (WA): IASP Press, 2010: 547–65

    Google Scholar 

  104. Guay DR. Use of oral oxymorphone in the elderly. Consult Pharm 2007; 22: 417–30

    Article  PubMed  Google Scholar 

  105. Fitzcharles MA, Shir Y. Pain management: opioid guidelines. Helpful for the rheumatologist? Nat Rev Rheumatol 2009; 5: 242–4

    Article  PubMed  CAS  Google Scholar 

  106. Weiner D, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 1998; 44: 217–21

    Article  PubMed  CAS  Google Scholar 

  107. Schnitzer TJ, Gray WL, Paster RZ, et al. Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol 2000; 27: 772–8

    PubMed  CAS  Google Scholar 

  108. Wilder-Smith CH, Hill L, Spargo K, et al. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAIDs: a randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001; 91: 23–31

    Article  PubMed  CAS  Google Scholar 

  109. Ruoff GE, Rosenthal N, Jordan D, et al., Protocol CAPSS-112 Study Group. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multi-center, randomized, double blind, placebo-controlled outpatient study. Clin Ther 2003; 23: 1123–40

    Article  Google Scholar 

  110. Babul N, Noveck R, Chipman H, et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manag 2004; 28: 59–71

    Article  CAS  Google Scholar 

  111. Beaulieu AD, Peloso PM, Haraoui B, et al. Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: a randomized controlled trial. Pain Res Manag 2008; 13: 103–10

    PubMed  CAS  Google Scholar 

  112. Barnung SK, Treschow M, Borgbjerg FM. Respiratory depression following oral tramadol in a patient with impaired renal function. Pain 1997; 71: 111–2

    Article  PubMed  CAS  Google Scholar 

  113. Likar R, Wittels M, Molnar M, et al. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study. Clin Ther 2006; 28: 2022–39

    Article  PubMed  CAS  Google Scholar 

  114. Wade WE, Spruill WJ. Tapentadol hydrochloride: a centrally acting oral analgesic. Clin Ther 2009; 31: 2804–18

    Article  PubMed  CAS  Google Scholar 

  115. Lussier D, Portenoy RK. Adjuvant analgesics in pain management. In: Doyle D, Hanks G, Cherny N, et al., editors. Oxford textbook of palliative medicine. 3rd ed. Oxford: Oxford University Press, 2003: 349–77

    Google Scholar 

  116. Onghena P, Van Houdenhov B. Antidepressant-induced analgesia in chronic nonmalignant pain: a meta-analysis of 39 placebo controlled studies. Pain 1992; 49: 205–19

    Article  PubMed  CAS  Google Scholar 

  117. Max MB. Antidepressants as analgesics. In: Fields HL, Liebeskin JC, editors. Progress in pain research management. Seattle (WA): IASP Press, 1994: 229–46

    Google Scholar 

  118. Lynch ME. Antidepressants as analgesics: a review of random controlled trials examining analgesic effects of antidepressant agents. J Psychiatry Neurosci 2001; 26: 30–6

    PubMed  CAS  Google Scholar 

  119. McQuay H, Carroll D, Jadad AR, et al. Anticonvulsant drugs for management of pain: a systemic review. BMJ 1995; 311: 1047–52

    Article  PubMed  CAS  Google Scholar 

  120. Rogawski MA, Loscher W. The neurobiology of anti-epileptic drugs for the treatment of nonepileptic conditions. Nat Med 2004; 10: 685–92

    Article  PubMed  CAS  Google Scholar 

  121. Chappell AS, Ossanna MJ, Liu-Seifert H, et al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 2009; 146: 253–60

    Article  PubMed  CAS  Google Scholar 

  122. Preskorn SH, Irwin HA. Toxicity of tricyclic antidepressants — kinetics, mechanism, intervention: a review. J Clin Psychiatry 1982; 43: 151–6

    PubMed  CAS  Google Scholar 

  123. Glassman AH, Bigger Jr JT. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: a review. Arch Gen Psychiatr 1981; 38: 815–20

    Article  PubMed  CAS  Google Scholar 

  124. Jaffe M, Iacobelis D, Young JP, et al. Post-hoc results show beneficial effects of pregabalin in patients with osteoarthritis of the hip [abstract]. Arthritis Rheum 2000; 43 Suppl.: 1621

    Google Scholar 

  125. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev 2003; 55: 1–20

    Article  PubMed  CAS  Google Scholar 

  126. Dominkus M, Nicolakis M, Kotz R, et al. Comparison of tissue and plasma levels of ibuprofen after oral and topical administration. Arzneimittelforschung 1996; 46: 1138–43

    PubMed  CAS  Google Scholar 

  127. Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases. Drugs 2000; 2000: 555–74

    Article  Google Scholar 

  128. Lynch ME, Clark AJ, Sawnyok J. Topical amitriptyline, ketamine and a combination of both in the treatment of neuropathic pain. Clin J Pain 2003; 19: 323–7

    Article  PubMed  CAS  Google Scholar 

  129. Bookman AA, Williams KS, Stainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 2004; 171: 333–8

    Article  PubMed  Google Scholar 

  130. Mason L, Moore RA, Derry S, et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004; 328: 991–4

    Article  PubMed  CAS  Google Scholar 

  131. Mason L, Moore RA, Edwards JE, et al. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord 2004; 19: 5–28

    Google Scholar 

  132. Mason L, Moore RA, Edwards JE, et al. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ 2004; 328: 991–4

    Article  PubMed  CAS  Google Scholar 

  133. Harvey WF, Hunter DJ. The role of analgesics and intraarticular injections in disease management. Rheum Dis Clin N Am 2008; 34: 777–88

    Article  Google Scholar 

  134. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol 2004; 31: 2002–12

    PubMed  CAS  Google Scholar 

  135. Barkin RL. Reducing cardiovascular risks of nonsteroidal anti-inflammatory drugs by using topical formulations [letter]. Am J Cardiol 2009 Nov 1; 104: 1315

    Article  PubMed  Google Scholar 

  136. Moore RA, Tramer MR, Carroll D, et al. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998; 316: 333–8

    Article  PubMed  CAS  Google Scholar 

  137. Lin J, Zhang W, Jones A, et al. Efficacy of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004; 329(7461): 324–7

    Article  PubMed  CAS  Google Scholar 

  138. Towheed TE. Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials. J Rheumatol 2006; 33: 567–73

    PubMed  CAS  Google Scholar 

  139. Altman R, Barkin RL. Topical therapy for osteoarthritis: clinical and pharmacologic perspectives. Postgrad Med 2009; 121: 139–47

    Article  PubMed  Google Scholar 

  140. Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol 1999; 11: 417–21

    Article  PubMed  CAS  Google Scholar 

  141. Meenagh GK, Patton J, Kynes C, et al. A randomized control trial of intra-articular corticosteroid injection of the carpometacarpal joint of the thumb in osteoarthritis. Ann Rheum Dis 2004; 63: 1260–3

    Article  PubMed  CAS  Google Scholar 

  142. Gaujoux-Viala C, Dougados M, Gossec L. Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomized controlled trials. Ann Rheum Dis 2009; 68: 1843–9

    Article  PubMed  CAS  Google Scholar 

  143. Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005; 18: CD005321

    Google Scholar 

  144. Reichenbach S, Blank S, Rutjes AW, et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum 2007; 57: 1410–18

    Article  PubMed  Google Scholar 

  145. Brzusek D, Petron D. Treating knee osteoarthritis with intrarticular hyaluronans. Curr Med Res Opin 2008; 24: 3307–22

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this review.

Mary-Ann Fitzcharles has received speaker or consultant honoraria from Lilly, Boehringer Ingelheim and Pfizer. David Lussier has received speaker or consultant honoraria from Janssen-Ortho, Merck-Frosst, Purdue Pharma and Pfizer. Yoram Shir has no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Montreal General Hospital Pain Centre, Montreal General Hospital, McGill University, 1650 Cedar Avenue, Montreal, Quebec, Canada, H3G 1A4

    Mary-Ann Fitzcharles, David Lussier & Yoram Shir

  2. Division of Rheumatology, McGill University, Montreal, Quebec, Canada

    Mary-Ann Fitzcharles

  3. Institut universitaire de gériatrie de Montréal, University of Montreal, Montreal, Quebec, Canada

    David Lussier

Authors
  1. Mary-Ann Fitzcharles
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Lussier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoram Shir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary-Ann Fitzcharles.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fitzcharles, MA., Lussier, D. & Shir, Y. Management of Chronic Arthritis Pain in the Elderly. Drugs Aging 27, 471–490 (2010). https://doi.org/10.2165/11536530-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11536530-000000000-00000

Keywords

Search

Navigation